Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …

OBJECTIVE: To perform a systematic review and meta-analysis evaluating the efficacy of
adjuvant human papillomavirus (HPV) vaccination in preventing recurrent cervical …

We evaluated the efficacy of the human papillomavirus (HPV)− 16/18 AS04‐adjuvanted
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …

Objective: To assess evidence on the efficacy of adjuvant human papillomavirus (HPV)
vaccination in patients treated for HPV-related disease across different susceptible organ …

Introduction Human papillomavirus (HPV) vaccination is essential for cervical cancer
prevention. However, the value of HPV vaccination in the context excisional treatment of …

Background: Recent studies have shown preliminary evidence that vaccination against
human papillomavirus (HPV) could decrease the risk of persistent/recurrent HSIL in women …

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-
grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to …

Introduction In this review and meta‐analysis we aimed to investigate whether human
papilloma virus (HPV) vaccination administered after excisional treatment of cervical …

Objective To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of
HPV infection and recurrent diseases related to HPV infection in individuals undergoing …

Background In women vaccinated against human papillomavirus (HPV), reductions in
cervical disease and related procedures results in more women having intact transformation …